File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The use of sex hormones in women with rheumatological diseases

TitleThe use of sex hormones in women with rheumatological diseases
Authors
KeywordsArthritis
Contraceptives
Hormonal
Hormone replacement therapy
Lupus erythematosus
Oral
Rheumatic diseases
Rheumatoid
Systemic
Issue Date2011
PublisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.html
Citation
Hong Kong Medical Journal, 2011, v. 17 n. 6, p. 487-491 How to Cite?
Abstract
A number of rheumatological diseases predominantly affect women of reproductive age. There has always been concern that the use of oestrogen-containing agents such as combined hormonal contraception and hormone therapy might aggravate these conditions. This article reviews the up-to-date evidence regarding the safety of using these agents in women with various rheumatological diseases, with emphasis on systemic lupus erythematosus and rheumatoid arthritis. In the absence of antiphospholipid antibody or other prothrombotic risk factors, combined hormonal contraception is not contra-indicated in most rheumatological conditions including inactive systemic lupus erythematosus. Moreover, hormone therapy is generally not contra-indicated except for women with active systemic lupus erythematosus disease where its effect on disease flare is less clear and individual judgement is required.
DescriptionAuthor Chinese name: Raymond HW Li 李幸奐, Ailsa E Gebbie, Raymond WS Wong 黃煥星, Ernest HY Ng 吳鴻裕, Anna F Glasier, PC Ho 何柏松
Persistent Identifierhttp://hdl.handle.net/10722/152944
ISSN
2013 SCImago Journal Rankings: 0.293
References

 

DC FieldValueLanguage
dc.contributor.authorLi, RHWen_HK
dc.contributor.authorGebbie, AEen_HK
dc.contributor.authorWong, RWSen_HK
dc.contributor.authorNg, EHYen_HK
dc.contributor.authorGlasier, AFen_HK
dc.contributor.authorHo, PCen_HK
dc.date.accessioned2012-07-16T09:52:55Z-
dc.date.available2012-07-16T09:52:55Z-
dc.date.issued2011en_HK
dc.identifier.citationHong Kong Medical Journal, 2011, v. 17 n. 6, p. 487-491en_HK
dc.identifier.issn1024-2708en_HK
dc.identifier.urihttp://hdl.handle.net/10722/152944-
dc.descriptionAuthor Chinese name: Raymond HW Li 李幸奐, Ailsa E Gebbie, Raymond WS Wong 黃煥星, Ernest HY Ng 吳鴻裕, Anna F Glasier, PC Ho 何柏松-
dc.description.abstractA number of rheumatological diseases predominantly affect women of reproductive age. There has always been concern that the use of oestrogen-containing agents such as combined hormonal contraception and hormone therapy might aggravate these conditions. This article reviews the up-to-date evidence regarding the safety of using these agents in women with various rheumatological diseases, with emphasis on systemic lupus erythematosus and rheumatoid arthritis. In the absence of antiphospholipid antibody or other prothrombotic risk factors, combined hormonal contraception is not contra-indicated in most rheumatological conditions including inactive systemic lupus erythematosus. Moreover, hormone therapy is generally not contra-indicated except for women with active systemic lupus erythematosus disease where its effect on disease flare is less clear and individual judgement is required.en_HK
dc.languageengen_US
dc.publisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.htmlen_HK
dc.relation.ispartofHong Kong Medical Journalen_HK
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.subjectArthritisen_HK
dc.subjectContraceptivesen_HK
dc.subjectHormonalen_HK
dc.subjectHormone replacement therapyen_HK
dc.subjectLupus erythematosusen_HK
dc.subjectOralen_HK
dc.subjectRheumatic diseasesen_HK
dc.subjectRheumatoiden_HK
dc.subjectSystemicen_HK
dc.subject.meshArthritis, Rheumatoid-
dc.subject.meshContraceptives, Oral, Combined-
dc.subject.meshContraceptives, Oral, Hormonal-
dc.subject.meshHormone Replacement Therapy-
dc.subject.meshLupus Erythematosus, Systemic-
dc.titleThe use of sex hormones in women with rheumatological diseasesen_HK
dc.typeArticleen_HK
dc.identifier.emailLi, RHW: raymondli@hku.hken_HK
dc.identifier.emailNg, EHY: nghye@hku.hken_HK
dc.identifier.emailHo, PC: pcho@hku.hken_HK
dc.identifier.authorityLi, RHW=rp01649en_HK
dc.identifier.authorityNg, EHY=rp00426en_HK
dc.identifier.authorityHo, PC=rp00325en_HK
dc.description.naturepublished_or_final_version-
dc.identifier.pmid22147320en_HK
dc.identifier.scopuseid_2-s2.0-83255176267en_HK
dc.identifier.hkuros201400en_US
dc.identifier.hkuros222176-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-83255176267&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume17en_HK
dc.identifier.issue6en_HK
dc.identifier.spage487en_HK
dc.identifier.epage491en_HK
dc.publisher.placeHong Kongen_HK
dc.identifier.scopusauthoridLi, RHW=7404724295en_HK
dc.identifier.scopusauthoridGebbie, AE=6602904291en_HK
dc.identifier.scopusauthoridWong, RWS=34875928200en_HK
dc.identifier.scopusauthoridNg, EHY=35238184300en_HK
dc.identifier.scopusauthoridGlasier, AF=35370179000en_HK
dc.identifier.scopusauthoridHo, PC=7402211440en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats